Literature DB >> 20628359

Duration of expression and activity of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery.

Jason B Bell1, Elena L Aronovich, Jeffrey M Schreifels, Thomas C Beadnell, Perry B Hackett.   

Abstract

The Sleeping Beauty (SB) transposon system can direct integration of DNA sequences into mammalian genomes. The SB system comprises a transposon and transposase that "cuts" the transposon from a plasmid and "pastes" it into a recipient genome. The transposase gene may integrate very rarely and randomly into genomes, which has led to concerns that continued expression might support continued remobilization of transposons and genomic instability. Consequently, we measured the duration of SB11 transposase expression needed for remobilization to determine whether continued expression might be a problem. The SB11 gene was expressed from the plasmid pT2/mCAGGS-Luc//UbC-SB11 that contained a luciferase expression cassette in a hyperactive SB transposon. Mice were imaged and killed at periodic intervals out to 24 weeks. Over the first 2 weeks, the number of plasmids with SB11 genes and SB11 mRNA dropped about 90 and 99.9%, respectively. Expression of the luciferase reporter gene in the transposon declined about 99% and stabilized for 5 months at nearly 1,000-fold above background. In stark contrast, transposition-supporting levels of SB11 mRNA lasted only about 4 days postinfusion. Thus, within the limits of current technology, we show that SB transposons appear to be as stably integrated as their viral counterparts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628359      PMCID: PMC2951564          DOI: 10.1038/mt.2010.152

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  46 in total

1.  Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA.

Authors:  Walter Rossmanith; Monika Chabicovsky; Kurt Herkner; Rolf Schulte-Hermann
Journal:  DNA Cell Biol       Date:  2002-11       Impact factor: 3.311

2.  Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon.

Authors:  Zongbin Cui; Aron M Geurts; Geyi Liu; Christopher D Kaufman; Perry B Hackett
Journal:  J Mol Biol       Date:  2002-05-17       Impact factor: 5.469

3.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.

Authors:  N S Yew; M Przybylska; R J Ziegler; D Liu; S H Cheng
Journal:  Mol Ther       Date:  2001-07       Impact factor: 11.454

Review 5.  Progress and prospects: naked DNA gene transfer and therapy.

Authors:  H Herweijer; J A Wolff
Journal:  Gene Ther       Date:  2003-03       Impact factor: 5.250

Review 6.  Cooperation of liver cells in health and disease.

Authors:  Z Kmieć
Journal:  Adv Anat Embryol Cell Biol       Date:  2001       Impact factor: 1.231

7.  Gene transfer into genomes of human cells by the sleeping beauty transposon system.

Authors:  Aron M Geurts; Ying Yang; Karl J Clark; Geyi Liu; Zongbin Cui; Adam J Dupuy; Jason B Bell; David A Largaespada; Perry B Hackett
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

8.  Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.

Authors:  Geyi Liu; Elena L Aronovich; Zongbin Cui; Chester B Whitley; Perry B Hackett
Journal:  J Gene Med       Date:  2004-05       Impact factor: 4.565

9.  AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

Authors:  Catherine S Manno; Amy J Chew; Sylvia Hutchison; Peter J Larson; Roland W Herzog; Valder R Arruda; Shing Jen Tai; Margaret V Ragni; Arthur Thompson; Margareth Ozelo; Linda B Couto; Debra G B Leonard; Frederick A Johnson; Alan McClelland; Ciaran Scallan; Erik Skarsgard; Alan W Flake; Mark A Kay; Katherine A High; Bertil Glader
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

10.  Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.

Authors:  Jacob Giehm Mikkelsen; Stephen R Yant; Leonard Meuse; Zan Huang; Hui Xu; Mark A Kay
Journal:  Mol Ther       Date:  2003-10       Impact factor: 11.454

View more
  27 in total

1.  Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects.

Authors:  Johann Urschitz; Miyuri Kawasumi; Jesse Owens; Kazuto Morozumi; Hideaki Yamashiro; Ilko Stoytchev; Joel Marh; James A Dee; Kris Kawamoto; Craig J Coates; Joseph M Kaminski; Pawel Pelczar; Ryuzo Yanagimachi; Stefan Moisyadi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 2.  Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

Authors:  Perry B Hackett; Elena L Aronovich; David Hunter; Myra Urness; Jason B Bell; Steven J Kass; Laurence J N Cooper; Scott McIvor
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

Review 3.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

4.  Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo.

Authors:  Kelly M Podetz-Pedersen; Vaiva Vezys; Nikunj V Somia; Stephen J Russell; R Scott McIvor
Journal:  Hum Gene Ther       Date:  2014-09-22       Impact factor: 5.695

5.  Rational design for enhanced gene therapy with DNA transposons.

Authors:  Perry B Hackett; Elena L Aronovich
Journal:  Mol Ther       Date:  2014-09       Impact factor: 11.454

6.  Prolonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease.

Authors:  Elena L Aronovich; Kendra A Hyland; Bryan C Hall; Jason B Bell; Erik R Olson; Myra Urness Rusten; David W Hunter; N Matthew Ellinwood; R Scott McIvor; Perry B Hackett
Journal:  Hum Gene Ther       Date:  2017-05-19       Impact factor: 5.695

Review 7.  Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers.

Authors:  Xiaomei Hou; Yan Du; Yang Deng; Jianfeng Wu; Guangwen Cao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

8.  Synergetic Targeted Delivery of Sleeping-Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage-Displayed Targeting Peptide.

Authors:  Kun Ma; Dong-Dong Wang; Yiyang Lin; Jianglin Wang; Valery Petrenko; Chuanbin Mao
Journal:  Adv Funct Mater       Date:  2013-03-06       Impact factor: 18.808

Review 9.  Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.

Authors:  Perry B Hackett; David A Largaespada; Kirsten C Switzer; Laurence J N Cooper
Journal:  Transl Res       Date:  2013-01-10       Impact factor: 7.012

10.  Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection.

Authors:  Jason B Bell; Kelly M Podetz-Pedersen; Elena L Aronovich; Lalitha R Belur; R Scott McIvor; Perry B Hackett
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.